RS62641B1 - Farmaceutski preparat ugljenih hidrata za terapeutsku upotrebu - Google Patents

Farmaceutski preparat ugljenih hidrata za terapeutsku upotrebu

Info

Publication number
RS62641B1
RS62641B1 RS20211212A RSP20211212A RS62641B1 RS 62641 B1 RS62641 B1 RS 62641B1 RS 20211212 A RS20211212 A RS 20211212A RS P20211212 A RSP20211212 A RS P20211212A RS 62641 B1 RS62641 B1 RS 62641B1
Authority
RS
Serbia
Prior art keywords
carbohydrates
pharmaceutical preparation
therapeutic use
therapeutic
pharmaceutical
Prior art date
Application number
RS20211212A
Other languages
English (en)
Inventor
Agnes Rafalko
Tatyana Chernenko
Original Assignee
Glycomine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycomine Inc filed Critical Glycomine Inc
Publication of RS62641B1 publication Critical patent/RS62641B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
RS20211212A 2013-09-16 2014-09-16 Farmaceutski preparat ugljenih hidrata za terapeutsku upotrebu RS62641B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361878591P 2013-09-16 2013-09-16
EP14851464.9A EP3046537B1 (en) 2013-09-16 2014-09-16 Pharmaceutical preparation of carbohydrates for therapeutic use
PCT/US2014/055921 WO2015053910A2 (en) 2013-09-16 2014-09-16 Pharmaceutical preparation of carbohydrates for therapeutic use

Publications (1)

Publication Number Publication Date
RS62641B1 true RS62641B1 (sr) 2021-12-31

Family

ID=52813726

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20211212A RS62641B1 (sr) 2013-09-16 2014-09-16 Farmaceutski preparat ugljenih hidrata za terapeutsku upotrebu

Country Status (13)

Country Link
US (5) US20160228364A1 (sr)
EP (2) EP3046537B1 (sr)
CY (1) CY1125361T1 (sr)
DK (1) DK3046537T3 (sr)
ES (1) ES2892314T3 (sr)
HR (1) HRP20211564T1 (sr)
HU (1) HUE056624T2 (sr)
LT (1) LT3046537T (sr)
PL (1) PL3046537T3 (sr)
PT (1) PT3046537T (sr)
RS (1) RS62641B1 (sr)
SI (1) SI3046537T1 (sr)
WO (1) WO2015053910A2 (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3134828A1 (en) * 2019-03-29 2020-10-08 Glycomine, Inc. Liposomal formulations, and methods of using and preparing thereof
US11058637B1 (en) * 2020-11-25 2021-07-13 King Abdulaziz University Surface-modified emulsomes for intranasal delivery of drugs
WO2023225102A1 (en) * 2022-05-18 2023-11-23 Glycomine, Inc. Continuous flow methods for producing mannose-1-phosphate, polymorphs of mannose-1-phosphate, and compositions and uses related thereto

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US7189705B2 (en) * 2000-04-20 2007-03-13 The University Of British Columbia Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
US7011845B2 (en) * 2000-05-09 2006-03-14 Mcp Hahnemann University β-glucans encapsulated in liposomes
WO2004103510A2 (en) * 2003-05-14 2004-12-02 The Regents Of The University Of Colorado Methods and apparatus using electrostatic atomization to form liquid vesicles
FR2897779B1 (fr) 2006-02-24 2009-04-17 Orphan Europ Sarl Manossyl-1 phosphates, procede de preparation et utilisation en therapeutique, notamment vis-a-vis dy syndrome cdg-la
CA2719567A1 (en) 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
US20120135064A1 (en) * 2009-05-27 2012-05-31 Northeastern University Conjugated nanodelivery vehicles
EP2516010A2 (en) 2009-12-23 2012-10-31 Novartis AG Lipids, lipid compositions, and methods of using them
US20110257233A1 (en) 2010-03-19 2011-10-20 Sanford-Burnham Medical Research Institute Benzoisothiazolones as inhibitors of phosphomannose isomerase
CA2807141C (en) * 2010-07-31 2019-02-26 The Scripps Research Institute Compositions and methods for inducing immune tolerance

Also Published As

Publication number Publication date
US20180036239A1 (en) 2018-02-08
DK3046537T3 (da) 2021-10-11
US20160228364A1 (en) 2016-08-11
US20200246266A1 (en) 2020-08-06
EP3046537A4 (en) 2017-04-19
EP3954360A3 (en) 2022-06-01
US20220110871A1 (en) 2022-04-14
HUE056624T2 (hu) 2022-02-28
HRP20211564T1 (hr) 2022-01-21
US11045419B2 (en) 2021-06-29
SI3046537T1 (sl) 2022-01-31
US10449149B2 (en) 2019-10-22
LT3046537T (lt) 2021-12-10
PT3046537T (pt) 2021-10-07
EP3046537A2 (en) 2016-07-27
WO2015053910A3 (en) 2015-06-18
WO2015053910A2 (en) 2015-04-16
ES2892314T3 (es) 2022-02-03
EP3046537B1 (en) 2021-07-14
PL3046537T3 (pl) 2022-01-31
CY1125361T1 (el) 2023-03-24
EP3954360A2 (en) 2022-02-16
US20240082155A1 (en) 2024-03-14

Similar Documents

Publication Publication Date Title
IL287516A (en) Medicinal uses of empagliflozin
HRP20190101T1 (hr) Terapeutske uporabe empagliflozina
HK1213818A1 (zh) 依帕列淨的治療用途
SI2981271T1 (sl) Terapevtske uporabe empagliflozina
SI3228313T1 (sl) Odmerne oblike in terapevtske uporabe L-4-klorokinurenina
ZA201600027B (en) Pharmaceutical preparation
EP2968179A4 (en) RETARD-PRESENTATIONS
PL3046537T3 (pl) Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego
HK1204916A1 (en) Pharmaceutical application of anhydroicaritin
EP2984170A4 (en) USE OF ANTIBODY UREASE CONJUGATES FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
ZA201506465B (en) Pharmaceutical preparation
EP3052475A4 (en) Pharmaceutical use of 3-benzylsulfonylpropionitrile
GB201319595D0 (en) Combination of Analgesic drugs
GB201316468D0 (en) Combination of analgesic drugs
GB201318230D0 (en) Solutions for administration of pharmaceuticals